Qilu Pharmaceutical is dedicated to safeguarding human health, committed to meeting societal needs, and driven by advanced science and technology, focusing on the research and development of drugs for common diseases, frequently occurring diseases, and other serious conditions that harm human health.
Headquartered in Jinan, Shandong Province, the company is a large comprehensive modern pharmaceutical enterprise in China, specializing in the research, development, production, and sales of pharmaceutical preparations and active pharmaceutical ingredients for the treatment of tumors, cardiovascular and cerebrovascular diseases, anti-infectives, psychiatric and neurological disorders, and ophthalmic diseases. The company adheres to an innovation-driven development strategy, with market demand at its core and product innovation as a priority. It extensively expands domestic and international R&D collaborations, emphasizes talent acquisition and cultivation, and has built a high-quality research team. With professional and efficient R&D capabilities, it has successfully developed nearly a hundred new drugs, establishing a rational pipeline for future growth. Multiple research projects have been awarded national and provincial science and technology progress awards, creating significant social benefits.
The company has established nine major production bases for preparations, chemical synthesis, biotechnology, antibiotic fermentation, and others, along with modern production workshops. Fully automated production lines and other key production equipment and testing instruments are procured from major global pharmaceutical equipment manufacturers. Several products, including antibiotic APIs, cephalosporin APIs, and anti-tumor APIs, have achieved domestic and even world-leading production capacity and standards. The company has built a rigorous quality control system and a comprehensive quality assurance framework and is among the first enterprises certified by the National Medical Products Administration (NMPA) for GMP compliance. Its non-sterile APIs (fermentation and chemical synthesis), sterile APIs, and multiple preparations have obtained certifications from drug regulatory authorities in the United States, the European Union, Australia, the United Kingdom, South Africa, and other countries and regions.
The company's product portfolio is scientifically structured and comprehensive, with over 270 marketed products featuring broad therapeutic coverage and systematic series. With reliable product quality and a customer-centric service ethos, it has established the Qilu brand in the pharmaceutical field, boasting a sales network spanning major provinces and cities across China and extending to North America, the EU, Japan, Australia, and other regions, presenting utterly trustworthy sincerity to China and the world.
"Great medicine requires utmost sincerity; family and country are paramount." The company has distilled a unique Qilu corporate culture and actively advocates the Qilu spirit of "Only with a state and a factory can we have our happy family," achieving mutual growth for employees and the enterprise. While developing rapidly, it fulfills social responsibilities, aids those in distress, and dedicates itself to charity, showcasing the development and takeoff of China's national pharmaceutical industry with remarkable achievements and proud spirit.
What does Qilu Pharmaceutical Group Co., Ltd. require? Who is Qilu Pharmaceutical Group hiring? Qilu Pharmaceutical Group recruitment: 生物/制药/化工/环保类占比最多占37.7%,其次是其他(研发和技术类)占32.2%. What education can get in at Qilu Pharmaceutical Group? 硕士占比最多占37.6%,其次是本科占34.1%. High education required at Qilu Pharmaceutical Group? 硕士占37.6%,博士占20.2%. Work experience required at Qilu Pharmaceutical Group? 不限占比最多占30.1%,其次是3-5年占27.6%. Where are the job locations at Qilu Pharmaceutical Group? 济南占比最多占76.2%,其次是北京占6.8%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows